-
-
-
-
-
-
-
Amylyx Pharmaceuticals Reports First Quarter 2026 Financial Results
-
-
-
-
-
-
-
Amylyx Pharmaceuticals, Inc. (AMLX) Tops Q3 EPS by 8c
-
-
-
-
-
-
-
Amylyx Pharmaceuticals Reports Second Quarter 2025 Financial Results
-
-
-
-
-
-
-
Amylyx Pharmaceuticals Announces Positive Long-Term Results from Phase 2 HELIOS Clinical Trial of AMX0035 in People with Wolfram Syndrome
-
-
-
-
-
-
-
Amylyx Pharmaceuticals, Inc. (AMLX) Tops Q4 EPS by 1c
-
-
-
-
-
-
-
Amylyx Pharmaceuticals Announces Pivotal Phase 3 LUCIDITY Trial Design for GLP-1 Receptor Antagonist (Avexitide) in Post-Bariatric Hypoglycemia
-
-
-
-
-
-
-
Amylyx Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 8, 2024
-
1,218,242 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

